Article Information
History
- March 15, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Hassan Alkharaan1,#,
- Shaghayegh Bayati5,#,
- Cecilia Hellström5,
- Annika Olsson2,
- Karin Lindahl2,4,
- Gordana Bogdanovic3,
- Soo Aleman2,4,
- Georgios Tsilingaridis1,
- Patricia De Palma1,
- Sophia Hober6,
- Anna Månberg5,
- Peter Nilsson5,
- Elisa Pin5,# and
- Margaret Sällberg Chen1,#,*
- 1Karolinska Institutet, Department of Dental Medicine, 14152, Stockholm, Sweden
- 2Karolinska University Hospital, Department of Infectious Diseases, 14186, Stockholm, Sweden
- 3Karolinska University Hospital, Department of Clinical Microbiology, 14186, Stockholm, Sweden
- 4Karolinska Institutet, Department of Medicine, 14186, Stockholm, Sweden
- 5Division of Affinity Proteomics, Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health (CBH), KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
- 6Division of Protein Technology, Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden
- ↵*Corresponding author:
Professor Margaret Sällberg Chen, Corresponding author contact information
Professor Margaret Sällberg Chen, Karolinska Institutet, Sweden. Email: Margaret.Chen{at}ki.se
Posted March 15, 2021.
Persisting Salivary IgG against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys
